基于Web of Science对肺癌病人放化疗研究文献进行计量学分析

Research on radiotherapy and chemotherapy for lung cancer patients based on Web of Science:a bibliometric analysis

目的:分析2014年—2022年世界上肺癌病人放化疗研究文献产出及被引情况,为相关领域人员开展研究工作提供参考与借鉴。方法:利用Web of Science的SCIE数据库,对2014年1月1日—2022年11月30日发表的有关肺癌病人放化疗研究的文献进行检索与统计,从发表国家与机构、研究方向、发表期刊、基金资助机构等方面及被引频次进行分析。结果:共检索到相关文献5526篇,发文量呈波动上升趋势,发表于96个国家/地区的5062所机构,共涉及848种期刊和71个研究方向。中国共发表文献1668篇,总被引频次21389次,篇均被引频次12.82次,均与发达国家存在较大差距。结论:2014—2022年欧美发达国家肺癌病人放化疗研究的文献产出和学术影响力较强;以中国为代表的发展中国家与此存在较大差距,但仍发挥了一定的引领示范作用。相关人员应着重关注Frontiers in Oncology、Lung Cancer、Radiotherapy and Oncology等期刊上发表的文献,及时掌握最新进展和发展趋势,拓展研究深度和广度,进一步提升影响力与认可度。

Objective:To analyze the output and citations of research literature on radiotherapy and chemotherapy for lung cancer patients worldwide from 2014 to 2022 and to provide reference for researchers in related fields to carry out research work.Methods:Related literature on radiotherapy and chemotherapy for lung cancer patients published from January 1,2014,to November 30,2022,were retrieved from the SCIE database of Web of Science.The included papers were analyzed from publishing countries and institutions,research directions,published journals,funding agencies,etc,and the frequency of citations.Results:A total of 5526 relevant documents were retrieved,and the number of published articles showed a fluctuating upward trend.A total of 5062 institutions in 96 countries/regions published relevant articles involving 848 journals and 71 research directions.China has published 1668 articles,with a total citation frequency of 21389 times and an average citation frequency of 12.82 times,in which there was a large gap between China and developed countries.Conclusions:From 2014 to 2022,the literature output and academic influence of research on radiotherapy and chemotherapy for lung cancer patients in developed countries in Europe and America are relatively strong.There is a significant gap in developing countries represented by China,but they still play a specific leading and exemplary role.Relevant personnel should focus on the literature published in journals such as Frontiers in Oncology,Lung Cancer,Radiotherapy and Oncology,keep abreast of the latest progress and development trends,expand the depth and breadth of research,and further enhance influence and recognition.